Skip to content

An Assessment of the Zephyr BioPatch and Its Ability to Monitor Patient Position

An Assessment of the Zephyr BioPatch and Its Ability to Monitor Patient Position

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02548624
Enrollment
0
Registered
2015-09-14
Start date
2016-11-30
Completion date
2017-02-28
Last updated
2017-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monitoring, Physiologic, Patient Positioning, Pressure Ulcer

Brief summary

The primary objective of the study is to examine the effectiveness of the Zephyr BioPatch in measuring position changes of a non-patient subject in a lab setting and to examine the effectiveness of the Zephyr BioPatch in measuring position changes of hospitalized patients.

Interventions

The ZephyrLIFE Hospital System includes the BioPatch™ device (consisting of the BioModule™ sensor, BioModule™ holder, and snap ECG electrodes), the ECHO radio system, and a software monitoring interface. The BioModule™ sensor is a Class II device, 510(k) cleared by the FDA, and commercially available. The ZephyrLIFE Hospital System stores, transmits and displays vital sign data including ECG, HR, RR, body orientation, and activity to caregivers via a central station.

Sponsors

Medtronic - MITG
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for Laboratory Subject: 1. Signed and dated informed consent by subject 2. Male or female of any race 3. At least 18 years of age 4. Willingness to have study device attached during study participation 5. Willingness to participate in all aspects of the study

Exclusion criteria

for Laboratory Subject: 1. Implanted pacemaker or defibrillator 2. Allergy or sensitivity to ECG leads or similar types of adhesive 3. History of hospital admission or a surgical procedure in the 60 days prior to study enrollment 4. BMI \> 30.0 Inclusion Criteria for Hospital Subjects: 1. Signed and dated informed consent by subject 2. Male or female of any race 3. At least 18 years of age 4. Expected hospitalized admission on the general care floor for at least three days 5. At risk for hospital-acquired pressure ulcers as defined by score on the Braden Scale of \< 18 6. Willingness to have study devices attached during study participation 7. Willingness to participate in all aspects of the study

Design outcomes

Primary

MeasureTime frameDescription
Body positionDuring a 2.5 hour lab observationBody position will be classified as facing right, facing left, facing down (prone), or facing up (supine).

Secondary

MeasureTime frameDescription
Performance of the Zephyr BioPatch position output in hospitalized patients of varying body mass indexes (BMI)During a 24 hospital observation.Body position when lying horizontally will be classified as facing right, facing left, facing down (prone), or facing up (supine).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026